Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H App

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Oncogene|September 1, 1993
H-ras and raf-1 cooperate in transformation of NIH3T3 fibroblastsA Cuadrado, J T Bruder, M A Heidaran, et al.
The Journal of Antibiotics|May 29, 1999
Asterriquinones produced by Aspergillus candidus inhibit binding of the Grb-2 adapter to phosphorylated EGF receptor tyrosine kinaseK A Alvi, H Pu, M Luche, et al.
Nature|July 30, 1992
Raf-1 activates MAP kinase-kinaseJ M Kyriakis, H App, X F Zhang, et al.
Oncogene|September 1, 1992
Ras controls coupling of growth factor receptors and protein kinase C in the membrane to Raf-1 and B-Raf protein serine kinases in the cytosolJ Troppmair, J T Bruder, H App, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|May 1, 1995
A tumor-derived protein which provides T-cell costimulation through accessory cell activationT J Powell, R Schreck, M McCall, et al.
Cancer Research|January 19, 1999
SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor typesT A Fong, L K Shawver, L Sun, et al.
Cancer Research|August 1, 1996
Flk-1 as a target for tumor growth inhibitionL M Strawn, G McMahon, H App, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Oncogene|September 1, 1993
H-ras and raf-1 cooperate in transformation of NIH3T3 fibroblastsA Cuadrado, J T Bruder, M A Heidaran, et al.
The Journal of Antibiotics|May 29, 1999
Asterriquinones produced by Aspergillus candidus inhibit binding of the Grb-2 adapter to phosphorylated EGF receptor tyrosine kinaseK A Alvi, H Pu, M Luche, et al.
Nature|July 30, 1992
Raf-1 activates MAP kinase-kinaseJ M Kyriakis, H App, X F Zhang, et al.
Oncogene|September 1, 1992
Ras controls coupling of growth factor receptors and protein kinase C in the membrane to Raf-1 and B-Raf protein serine kinases in the cytosolJ Troppmair, J T Bruder, H App, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|May 1, 1995
A tumor-derived protein which provides T-cell costimulation through accessory cell activationT J Powell, R Schreck, M McCall, et al.
Cancer Research|January 19, 1999
SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor typesT A Fong, L K Shawver, L Sun, et al.
Cancer Research|August 1, 1996
Flk-1 as a target for tumor growth inhibitionL M Strawn, G McMahon, H App, et al.
Pageof 2